This grant, offered by the National Institute on Drug Abuse (NIDA), is for the purpose of combating the increasing abuse, misuse, and diversion of prescription opioid analgesics. The primary goal is to support the development of innovative new approaches designed to significantly reduce their non-medical use. This includes efforts to reformulate opioid medications to be abuse-resistant, meaning an individual would be unable to divert them, or abuse-deterrent, making them unwilling to do so. Furthermore, the grant encourages the creation of novel medication dispensing devices. This initiative represents NIDA’s focused commitment to preventing drug diversion and misuse directly at the patient level.
Opportunity ID: 237724
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-14-013 |
| Funding Opportunity Title: | Abuse-Resistant and Abuse-Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 16, 2013 |
| Last Updated Date: | Oct 18, 2013 |
| Original Closing Date for Applications: | Oct 11, 2013 |
| Current Closing Date for Applications: | Nov 01, 2013 |
| Archive Date: | Dec 01, 2013 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Opioid analgesics are widely prescribed for the treatment of pain patients. The increase in prescription opioids abuse, misuse and diversion warrants the support of new approaches designed to reduce their non-medical use. Among potentially important steps towards the goal of safer opioid analgesics are the efforts to reformulate medication so that an individual would not be able (abuse resistance) or would not want (abuse deterrence) to divert the prescription drug, and to create innovative medication dispensing devices/gadgets. This FOA represents a focused effort of the National Institute on Drug Abuse (NIDA) on preventing diversion and misuse at the patient level. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modified Archive Date based on new Expiration Date, per NOT-OD-14-003. | Oct 18, 2013 | |
| Oct 18, 2013 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-14-013 |
| Funding Opportunity Title: | Abuse-Resistant and Abuse-Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 16, 2013 |
| Last Updated Date: | Oct 18, 2013 |
| Original Closing Date for Applications: | Oct 11, 2013 |
| Current Closing Date for Applications: | Nov 01, 2013 |
| Archive Date: | Dec 01, 2013 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Opioid analgesics are widely prescribed for the treatment of pain patients. The increase in prescription opioids abuse, misuse and diversion warrants the support of new approaches designed to reduce their non-medical use. Among potentially important steps towards the goal of safer opioid analgesics are the efforts to reformulate medication so that an individual would not be able (abuse resistance) or would not want (abuse deterrence) to divert the prescription drug, and to create innovative medication dispensing devices/gadgets. This FOA represents a focused effort of the National Institute on Drug Abuse (NIDA) on preventing diversion and misuse at the patient level. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-14-013 |
| Funding Opportunity Title: | Abuse-Resistant and Abuse-Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 18, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 11, 2013 |
| Archive Date: | Nov 11, 2013 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Opioid analgesics are widely prescribed for the treatment of pain patients. The increase in prescription opioids abuse, misuse and diversion warrants the support of new approaches designed to reduce their non-medical use. Among potentially important steps towards the goal of safer opioid analgesics are the efforts to reformulate medication so that an individual would not be able (abuse resistance) or would not want (abuse deterrence) to divert the prescription drug, and to create innovative medication dispensing devices/gadgets. This FOA represents a focused effort of the National Institute on Drug Abuse (NIDA) on preventing diversion and misuse at the patient level. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00181033 | Sep 11, 2013 | Nov 01, 2013 | View |
Package 1
Mandatory forms
237724 RR_SF424_1_2-1.2.pdf
237724 PerformanceSite_1_4-1.4.pdf
237724 RR_OtherProjectInfo_1_3-1.3.pdf
237724 RR_KeyPersonExpanded_1_2-1.2.pdf
237724 RR_Budget-1.1.pdf
237724 PHS398_CoverPageSupplement_1_4-1.4.pdf
237724 PHS398_ResearchPlan_1_3-1.3.pdf
237724 PHS398_Checklist_1_3-1.3.pdf
237724 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
237724 RR_SubawardBudget30-1.2.pdf
237724 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
